MAPT and Alzheimer disease: Previous basic research on AD-related mitochondrial dysfunction predominantly used rodent models with supraphysiological expression of Aβ and/or tau pathology, thus having limited capacity to reflect cellular perturbations in late-onset AD–relevant conditions (44).